VWF:CB activity was lower in the blood of patients with CAD than in patients without CAD, with values of 106.7% (82.1; 131.6) and 160.4% (112.5; 218.1), respectively (p < 0.001). This evidence concerns the gene VWF and coronary artery disorder.